World's Best Scientists 2026 revealed!
Antonio Lopez-Beltran

Antonio Lopez-Beltran

D-Index & Metrics

Medicine

D-Index
99
Citations
33360
World Ranking
8647
National Ranking
122

Antonio Lopez-Beltran publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Antonio Lopez-Beltran sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 873 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Antonio Lopez-Beltran D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Antonio Lopez-Beltran sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Antonio Lopez-Beltran is affiliated with the University of Córdoba in Spain and has contributed extensively to the field of medical research, with a primary focus on urology and oncology. Their work spans several subfields, including surgery, pulmonary and respiratory medicine, oncology, urology, and rheumatology.

The scientist has authored numerous publications in key research venues. Frequent publication venues for their work include:

  • European Urology
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • European Urology Oncology
  • Translational Andrology and Urology
  • Regular and Young Investigator Award Abstracts

Antonio Lopez-Beltran's research covers a variety of main topics, namely:

  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Urologic and reproductive health conditions
  • Renal cell carcinoma treatment

Recent notable papers by Lopez-Beltran include:

  • "The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer," 2020, Archives of Pathology & Laboratory Medicine
  • "Epigenetic modulations and lineage plasticity in advanced prostate cancer," 2020, Annals of Oncology
  • "Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma," 2020, Cancers
  • "Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer," 2021, JAMA Oncology
  • "Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer," 2020, Cells

The scientist frequently collaborates with:

  • Maria Rosaria Raspollini
  • Rodolfo Montironi
  • Alessia Cimadamore
  • Liang Cheng
  • Marina Scarpelli

In addition to journal articles, Antonio Lopez-Beltran has contributed to book publications, having published a title with Springer International Publishing titled Uropathology in 2020.

Best Publications

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • 2004 WHO Classification of the Renal Tumors of the Adults

    Antonio Lopez-Beltran;Marina Scarpelli;Rodolfo Montironi;Ziya Kirkali

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity

    Brian Shuch;Ali Amin;Andrew J. Armstrong;John N. Eble

  • Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.

    Liang Cheng;Antonio Lopez-Beltran;Francesco Massari;Gregory T MacLennan

  • CARCINOSARCOMA AND SARCOMATOID CARCINOMA OF THE BLADDER: CLINICOPATHOLOGICAL STUDY OF 41 CASES

    A. Lopez-Beltran;A. Pacelli;H.J. Rothenberg;P.C. Wollan

  • Small cell carcinoma of the urinary bladder

    Liang Cheng;Chong-Xian Pan M.D.;Ximing J. Yang M.D.;Antonio Lopez-Beltran

  • The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary:

    Rodolfo Montironi;Antonio Lopez-Beltran

  • Molecular pathology of lung cancer: key to personalized medicine.

    Liang Cheng;Riley E Alexander;Gregory T MacLennan;Oscar W Cummings

  • Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications

    Antonio Lopez-Beltran;Liang Cheng

  • Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference.

    Mahul B. Amin;Jonathan I. Epstein;Thomas M. Ulbright;Peter A. Humphrey

  • Molecular biology of prostatic intraepithelial neoplasia.

    David G. Bostwick;Anna Pacelli;Antonio Lopez-Beltran

  • OCT4: biological functions and clinical applications as a marker of germ cell neoplasia

    L. Cheng;M. T. Sung;P. Cossu-Rocca;T. D. Jones

  • Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential.

    Sueli Suzigan;Antonio López-Beltrán;Rodolfo Montironi;Ricardo Drut

  • Staging and reporting of urothelial carcinoma of the urinary bladder

    Liang Cheng;Rodolfo Montironi;Darrell D Davidson;Antonio Lopez-Beltran

  • Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis

    Timothy D. Jones;Mingsheng Wang;John N. Eble;Gregory T. MacLennan

  • Non-Invasive Urothelial Neoplasms: According to the Most Recent WHO Classification

    Antonio Lopez-Beltran;Rodolfo Montironi

  • Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.

    Liang Cheng;Timothy D. Jones;Ryan P. McCarthy;John N. Eble

  • Metabolic phenotype of bladder cancer

    Francesco Massari;Chiara Ciccarese;Matteo Santoni;Roberto Iacovelli

  • 2009 update on the classification of renal epithelial tumors in adults

    Antonio Lopez-Beltran;Jose C Carrasco;Liang Cheng;Marina Scarpelli

Frequent Co-Authors

Liang Cheng
Liang Cheng Brown University
Rodolfo Montironi
Rodolfo Montironi Marche Polytechnic University
Gregory T. MacLennan
Gregory T. MacLennan Case Western Reserve University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
John N. Eble
John N. Eble Indiana University
Guido Martignoni
Guido Martignoni University of Verona
Puay Hoon Tan
Puay Hoon Tan Duke NUS Graduate Medical School
Lars Egevad
Lars Egevad Karolinska Institute
Holger Moch
Holger Moch University of Zurich
Eva Comperat
Eva Comperat Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in healthcare can open many doors for students interested in medicine in the USA. Many prospective nurses now consider rn to bsn programs no clinicals for a flexible and accessible route to further education without in-person clinicals. These programs are ideal for working professionals seeking career progression or broader roles in healthcare.

For nurses aiming to advance further, there are options like the shortest online dnp program and 1 year dnp program online pathways. These accelerated Doctor of Nursing Practice programs enable experienced nurses to reach the highest clinical levels quickly, often within a year, offering more leadership and specialized roles.

Meanwhile, aspiring practical nurses can take advantage of fast track medical courses to begin their careers in healthcare in less time. These programs focus on getting students into the workforce efficiently, addressing the growing demand for healthcare professionals. Whether you're starting out or advancing your qualifications, these online pathways offer diverse, streamlined options for a successful medical career.

Best Scientists Citing Antonio Lopez-Beltran

Trending Scientists

Recently Published Articles